Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation

Autor: Julian Mangesius, Ivan Radovic, Malik Galijašević, Christian F. Freyschlag, Johannes Kerschbaumer, Lisa Maria Walchhofer, Elke R. Gizewski, Astrid E. Grams, Andreas Rietzler, Stephanie Mangesius, Martha Nowosielski, Ruth Steiger
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Current Oncology; Volume 28; Issue 6; Pages: 5041-5053
Current Oncology, Vol 28, Iss 424, Pp 5041-5053 (2021)
Current Oncology
ISSN: 1718-7729
DOI: 10.3390/curroncol28060424
Popis: Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the presumably “normal-appearing” brain following chemoradiation therapy (CRT) in GB patients in comparison to healthy controls. Twenty (seven female, thirteen male) GB patients underwent a 31P-MRS scan prior to surgery (baseline) and after three months of standard CRT (follow-up examination. The regions of interest “contrast-enhancing (CE) tumor” (if present), “adjacent to the (former) tumor”, “ipsilateral distant” hemisphere, and “contralateral” hemisphere were compared, differentiating between patients with stable (SD) and progressive disease (PD). Metabolite ratios PCr/ATP, Pi/ATP, PCr/Pi, PME/PDE, PME/PCr, and PDE/ATP were investigated. In PD, energy and membrane metabolism in CE tumor areas have a tendency to “normalize” under therapy. In different “normal-appearing” brain areas of GB patients, the energy and membrane metabolism either “normalized” or were “disturbed”, in comparison to baseline or controls. Differences were also detected between patients with SD and PD. 31P-MRS might contribute as an additional imaging biomarker for outcome measurement, which remains to be investigated in a larger cohort.
Databáze: OpenAIRE